HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, R. Articles by Arnaout, M. A. Search for Related Content PubMed PubMed Citation Articles by Li, R. Articles by Arnaout, M. A.

Characterization of a Conformationally Sensitive Murine Monoclonal Antibody Directed to the Metal Ion-Dependent Adhesion Site Face of Integrin CD11b¹

Leukocyte Biology and Inflammation Program, Structural Biology Program, Renal Unit, Massachusetts General Hospital, Charlestown, MA 02129, and Department of Medicine, Harvard Medical School, Boston, MA 02115

Integrin binding to physiologic ligands requires divalent cations and an inside-out-driven switch of the integrin to a high-affinity state. Divalent cations at the metal ion-dependent adhesion site (MIDAS) face of the subunit-derived A domain provide a direct bridge between ligands and the integrin, and it has been proposed that activation dependency is caused by reorientation of the surrounding residues relative to the metal ion, forming an optimal binding interface. To gain more insight into the functional significance of the protein movements on the MIDAS face, we raised and characterized a murine mAb 107 directed against the MIDAS face of the A domain from integrin CD11b. We find that mAb 107 behaves as a ligand mimic. It binds in a divalent-cation-dependent manner to solvent-exposed residues on the MIDAS face of CD11b, blocks interaction of 11bA or the holoreceptor with ligands, and inhibits spreading and phagocytosis by human neutrophils. However, in contrast to physiologic ligands, mAb 107 preferentially binds to the inactive low-affinity form of the integrin, suggesting that its antagonistic effects are exerted in part by stabilizing the receptor in the low-affinity state. These data support a functional relevance of the protein movements on the MIDAS face and suggest that stabilizing the A domain in the low-affinity state may have therapeutic benefit.

This article has been cited by other articles:

				V. Gupta, J. L. Alonso, T. Sugimori, M. Issafi, J.-P. Xiong, and M. A. Arnaout Role of the {beta}-Subunit Arginine/Lysine Finger in Integrin Heterodimer Formation and Function J. Immunol., February 1, 2008; 180(3): 1713 - 1718. [Abstract] [Full Text] [PDF]

				V. Gupta, A. Gylling, J. L. Alonso, T. Sugimori, P. Ianakiev, J.-P. Xiong, and M. Amin Arnaout The {beta}-tail domain ({beta}TD) regulates physiologic ligand binding to integrin CD11b/CD18 Blood, April 15, 2007; 109(8): 3513 - 3520. [Abstract] [Full Text] [PDF]

				J. Y. Park, M. Amin Arnaout, and V. Gupta A Simple, No-Wash Cell Adhesion-Based High-Throughput Assay for the Discovery of Small-Molecule Regulators of the Integrin CD11b/CD18 J Biomol Screen, April 1, 2007; 12(3): 406 - 417. [Abstract] [PDF]

				M. Shimaoka, M. Kim, E. H. Cohen, W. Yang, N. Astrof, D. Peer, A. Salas, A. Ferrand, and T. A. Springer AL-57, a ligand-mimetic antibody to integrin LFA-1, reveals chemokine-induced affinity up-regulation in lymphocytes PNAS, September 19, 2006; 103(38): 13991 - 13996. [Abstract] [Full Text] [PDF]

				A. Funaro, E. Ortolan, B. Ferranti, L. Gargiulo, R. Notaro, L. Luzzatto, and F. Malavasi CD157 is an important mediator of neutrophil adhesion and migration Blood, December 15, 2004; 104(13): 4269 - 4278. [Abstract] [Full Text] [PDF]

				K. Ajroud, T. Sugimori, W. H. Goldmann, D. M. Fathallah, J.-P. Xiong, and M. A. Arnaout Binding Affinity of Metal Ions to the CD11b A-domain Is Regulated by Integrin Activation and Ligands J. Biol. Chem., June 11, 2004; 279(24): 25483 - 25488. [Abstract] [Full Text] [PDF]